Patents by Inventor James A. Dromey

James A. Dromey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Soluble mediator
    Patent number: 11123403
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: September 21, 2021
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang
  • COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE
    Publication number: 20210115096
    Abstract: The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.
    Type: Application
    Filed: May 27, 2020
    Publication date: April 22, 2021
    Applicant: ImmusanT, Inc.
    Inventors: Robert P. Anderson, Jessica A. Stewart, James A. Dromey, Jason A. Tye-Din
  • Soluble Mediator
    Publication number: 20200078440
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Application
    Filed: August 21, 2019
    Publication date: March 12, 2020
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang, Maryam Rashidi
  • Soluble mediator
    Patent number: 10413589
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type I diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: September 17, 2019
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang
  • Soluble Mediator
    Publication number: 20190192624
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Application
    Filed: December 12, 2018
    Publication date: June 27, 2019
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang
  • Soluble mediator
    Patent number: 10328124
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: June 25, 2019
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang
  • COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE
    Publication number: 20190048047
    Abstract: The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.
    Type: Application
    Filed: June 18, 2018
    Publication date: February 14, 2019
    Applicant: ImmusanT, Inc.
    Inventors: Robert P. Anderson, Jessica A. Stewart, James A. Dromey, Jason A. Tye-Din
  • Soluble Mediator
    Publication number: 20180256679
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Application
    Filed: May 9, 2018
    Publication date: September 13, 2018
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang
  • Soluble mediator
    Patent number: 10010582
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: July 3, 2018
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang
  • Soluble Mediator
    Publication number: 20170232061
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Application
    Filed: December 19, 2016
    Publication date: August 17, 2017
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang, Maryam Rashidi
  • COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE
    Publication number: 20170158743
    Abstract: The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.
    Type: Application
    Filed: September 9, 2016
    Publication date: June 8, 2017
    Applicant: ImmusanT, Inc.
    Inventors: Robert P. Anderson, Jessica A. Stewart, James A. Dromey, Jason A. Tye-Din
  • Soluble mediator
    Patent number: 9585969
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: March 7, 2017
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang
  • Compositions for treatment of celiac disease
    Patent number: 9464120
    Abstract: The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: October 11, 2016
    Assignee: ImmusanT, Inc.
    Inventors: Robert P. Anderson, Jessica A. Stewart, James A. Dromey, Jason A. Tye-Din
  • COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE
    Publication number: 20150050303
    Abstract: The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.
    Type: Application
    Filed: August 13, 2014
    Publication date: February 19, 2015
    Applicant: ImmusanT, Inc.
    Inventors: Robert P. Anderson, Jessica A. Stewart, James A. Dromey, Jason A. Tye-Din
  • Soluble Mediator
    Publication number: 20140308209
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Application
    Filed: November 15, 2012
    Publication date: October 16, 2014
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang, Maryam Rashidi
  • Agents for the treatment of celiac disease
    Patent number: 8835603
    Abstract: The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: September 16, 2014
    Assignee: ImmusanT, Inc.
    Inventors: Robert P. Anderson, Jessica A. Stewart, James A. Dromey, Jason A. Tye-Din
  • COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE
    Publication number: 20110293644
    Abstract: The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.
    Type: Application
    Filed: November 30, 2009
    Publication date: December 1, 2011
    Applicant: IMMUSANT, INC.
    Inventors: Robert P. Anderson, Jessica A. Stewart, James A. Dromey, Jason A. Tye-Din